Company Update1 Min Read InvestyWise NewsonNovember 6, 2025 IFCI Limited Credit Ratings Reaffirmed by Brickwork Ratings Brickwork Ratings has reaffirmed the credit ratings for IFCI Limited’s debt instruments. The ratings for Non-Convertible…
Company Update2 Min Read InvestyWise NewsonNovember 6, 2025 Lupin Q2 FY26 Results – Strong Growth and Margin Improvement Lupin announced strong Q2 FY26 results, marked by significant sales growth and improved profitability. Sales reached INR 68,314 million, a 24%…
Company Results2 Min Read InvestyWise NewsonNovember 6, 2025 Shree Renuka Sugars Board Approves KBK Chem-Engineering Equity Conversion Shree Renuka Sugars’ board has approved the conversion of ₹573.65 million in loans to its wholly-owned subsidiary, KBK Chem-Engineering…
Company Update1 Min Read InvestyWise NewsonNovember 6, 2025 Canara Bank Shri Vijay Srirangan Ceases Role as Non-Executive Chairman Canara Bank announces the completion of Shri Vijay Srirangan’s tenure as Non-Executive Chairman. He ceased to be Part-Time Non-Official…
Company Update1 Min Read InvestyWise NewsonNovember 6, 2025 TVS Motor Company Divests Stake in Roppen Transportation Services TVS Motor Company has entered into agreements to sell its stake in Roppen Transportation Services Private Limited. The company will sell…
Corporate Action1 Min Read InvestyWise NewsonNovember 6, 2025 Infosys Sets Record Date for Equity Share Buyback Infosys has announced November 14, 2025, as the record date for its buyback of equity shares. This date is crucial for determining the…
Board Meeting2 Min Read InvestyWise NewsonNovember 6, 2025 Shree Renuka Sugars Board Approves Investment in Subsidiary & Financial Results for Q2 2026 Shree Renuka Sugars’ board has approved an investment in its wholly-owned subsidiary, KBK Chem-Engineering, converting ₹573.65 million…
Board Meeting1 Min Read InvestyWise NewsonNovember 6, 2025 Eris Lifesciences Board Meeting Scheduled to Approve Quarterly Results Eris Lifesciences has announced a board meeting scheduled for November 12, 2025, to review and approve the unaudited financial results for the…
Company Update2 Min Read InvestyWise NewsonNovember 6, 2025 Alivus Life Sciences Strong Q2FY26 Revenue Growth of 16% YoY Alivus Life Sciences reported strong financial results for Q2FY26, with revenue growth of 16% YoY, reaching Rs. 5,880 Mn. EBITDA margins…
Company Update1 Min Read InvestyWise NewsonNovember 6, 2025 Apollo Hospitals Strong Q2 FY26 Performance Driven by Healthcare Services Apollo Hospitals Enterprise Limited announced a strong financial performance for Q2 FY26. Consolidated Revenue grew by 13% to ₹63,035 million,…